1. Optic neuritis relapse within the three months before inclusion

2. Normal RNFL at OCT

3. Presence of other ocular pathology (glaucoma, cataract, retinopathy, anterior uveitis, myopia\>7 dioptrics, intraocular pressure\>20 mm Hg, amblyopia, retinal or optic head abnormalities (drusen, tilted disc)

4. Bilateral visual acuity \<1/20

5. Visual impairment caused by ocular flutter or nystagmus

6. Pregnancy or childbearing potential woman without contraception

7. Any general chronic handicapping disease other than MS

8. New treatment introduced less than 3 months prior to inclusion or less than 1 month for Fampridine

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

What this study is about